An Affinity-Enhanced Neutralizing Antibody against the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 gp41 Recognizes an Epitope between Those of 2F5 and 4E10

作者: Josh D. Nelson , Florence M. Brunel , Richard Jensen , Emma T. Crooks , Rosa M. F. Cardoso

DOI: 10.1128/JVI.02588-06

关键词: Molecular biologyEpitopeAlanine scanningNeutralizing antibodyBiologyNeutralizationGp41Epitope mappingVirologyAntigenAntibody

摘要: The membrane-proximal external region (MPER) of human immunodeficiency virus type 1 (HIV-1) gp41 bears the epitopes two broadly neutralizing antibodies (Abs), 2F5 and 4E10, making it a target for vaccine design. A third Ab, Fab Z13, had previously been mapped to an epitope that overlaps those 4E10 but only weakly neutralizes limited set primary isolates. Here, libraries Z13 variants displayed on phage were engineered affinity selected against MPER peptide recombinant gp41. high-affinity variant, designated Z13e1, was isolated found be approximately 100-fold improved over parental not in binding antigens also neutralization potency sensitive HIV-1. Alanine scanning residues 664 680 revealed N671 D674 are crucial recognition as well HIV-1 by Z13e1. Ab competition studies truncation peptides indicate Z13e1 binds with high between overlapping minimal WASLWNWFDITN. Still, remained about order magnitude less potent than several isolates pseudotyped sum our molecular analyses suggests segment is exposed functional envelope trimer access specific within this limited. Thus, ability MPER-bearing immunogens elicit HIV-1-neutralizing Abs may depend part recapitulating particular constraints imposes which binds.

参考文章(64)
Emma T. Crooks, Penny L. Moore, Douglas Richman, James Robinson, Jeffrey A. Crooks, Michael Franti, Norbert Schülke, James M. Binley, Characterizing anti-HIV monoclonal antibodies and immune sera by defining the mechanism of neutralization. Human antibodies. ,vol. 14, pp. 101- 113 ,(2006) , 10.3233/HAB-2005-143-407
A J Conley, M K Gorny, J A Kessler, L J Boots, M Ossorio-Castro, S Koenig, D W Lineberger, E A Emini, C Williams, S Zolla-Pazner, Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D. Journal of Virology. ,vol. 68, pp. 6994- 7000 ,(1994) , 10.1128/JVI.68.11.6994-7000.1994
Carlos F. Barbas, Phage Display: A Laboratory Manual ,(2004)
Nancy Sullivan, Ying Sun, Quentin Sattentau, Markus Thali, Dona Wu, Galina Denisova, Jonathan Gershoni, James Robinson, John Moore, Joseph Sodroski, CD4-Induced Conformational Changes in the Human Immunodeficiency Virus Type 1 gp120 Glycoprotein: Consequences for Virus Entry and Neutralization Journal of Virology. ,vol. 72, pp. 4694- 4703 ,(1998) , 10.1128/JVI.72.6.4694-4703.1998
Partha S. Chowdhury, Ira Pastan, Improving antibody affinity by mimicking somatic hypermutation in vitro. Nature Biotechnology. ,vol. 17, pp. 568- 572 ,(1999) , 10.1038/9872
R. D. Klausner, The need for a global HIV vaccine enterprise Science. ,vol. 300, pp. 2036- 2039 ,(2003) , 10.1126/SCIENCE.1086916
T Muster, F Steindl, M Purtscher, A Trkola, A Klima, G Himmler, F Rüker, H Katinger, A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. Journal of Virology. ,vol. 67, pp. 6642- 6647 ,(1993) , 10.1128/JVI.67.11.6642-6647.1993
A Björndal, H Deng, M Jansson, J R Fiore, C Colognesi, A Karlsson, J Albert, G Scarlatti, D R Littman, E M Fenyö, Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. Journal of Virology. ,vol. 71, pp. 7478- 7487 ,(1997) , 10.1128/JVI.71.10.7478-7487.1997
A Trkola, M Purtscher, T Muster, C Ballaun, A Buchacher, N Sullivan, K Srinivasan, J Sodroski, J P Moore, H Katinger, Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. Journal of Virology. ,vol. 70, pp. 1100- 1108 ,(1996) , 10.1128/JVI.70.2.1100-1108.1996